Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could ketamine be the key to easing sickle cell pain in kids?

NCT ID NCT07369024

First seen Feb 01, 2026 · Last updated Apr 30, 2026 · Updated 10 times

Summary

This study looks at whether adding a small amount of ketamine to standard pain medicine (like morphine) can better relieve severe pain in children and young adults with sickle cell disease. About 120 participants aged 5 to 20 will be randomly assigned to receive either standard care plus ketamine or standard care alone. The goal is to see if the ketamine group needs less opioid medicine and has lower pain scores.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Harbor UCLA Medical Center

    RECRUITING

    Torrance, California, 90509, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.